Skip to content

Nelarabine

Arranon, Atriance (nelarabine) is a small molecule pharmaceutical. Nelarabine was first approved as Arranon on 2005-10-28. It is used to treat t-cell leukemia in the USA. It has been approved in Europe to treat precursor t-cell lymphoblastic leukemia-lymphoma.
Trade Name Atriance
Common Name Nelarabine
Indication precursor t-cell lymphoblastic leukemia-lymphoma, t-cell leukemia
Drug Class Antineoplastics (arabinofuranosyl derivatives)
Nelarabine
Get full access now